405 Heron Drive Suite 200
Swedesboro, NJ 08085
Ph 800.331.8272
www.wedgewoodpharmacy.com

Wedgewood Compounding Pharmacy Press Room

Wedgewood Celebrates Groundbreaking Ceremony for New State-of-the-Art Veterinary Pharmacy
in Press Room - 02/22/2024
Wedgewood, a leading provider of compounded medications for animals, celebrated the groundbreaking ceremony for its new state-of-the-art veterinary pharmacy facility in Chandler, Arizona. The 90,000-square-foot facility, scheduled to open in early 2025, represents a significant investment in advancing veterinary care and will serve as a crucial distribution hub for the western United States.

Wedgewood Introduces Blue Rabbit, the Next-Generation Online Veterinary Pharmacy Solution
in Press Room - 01/19/2024
Wedgewood launches Blue Rabbit, a next-generation online pharmacy platform.

Wedgewood Named to Inc.’s Second Annual Power Partner Awards
in Press Room - 10/24/2023
Inc. Business Media today announced the second annual Power Partner Awards, honoring B2B organizations across the globe that have proven track records supporting entrepreneurs and helping businesses grow. The list recognizes 389 firms in marketing and advertising, health and wellness, financial services, legal, logistics, and productivity, as well as other areas of business. Wedgewood was honored as a Power Partner in the health and wellness category.

Wedgewood Pharmacy Merges with Blue Rabbit to Deliver Exceptional Veterinary Pharmacy Services
in Press Room - 06/14/2023
Wedgewood Pharmacy, the nation’s largest veterinary compounding pharmacy, announced its merger with Blue Rabbit, an emerging leader in veterinary prescription management and pharmacy solutions.

Wedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need
in Press Room - 02/27/2023
Wedgewood Pharmacy has acquired Front Range Laboratories (FRL) in Loveland, CO, which is a full-service testing laboratory that has been a trusted partner of compounding pharmacies for more than 25 years. The transaction closed on February 23; terms were not disclosed. Excel Partners served as financial advisor to Wedgewood Pharmacy.

FDA Announces Six-Month Delay in GFI #256 Enforcement Until April 2023
in Press Room - 09/12/2022
On September 9, 2022, the Food & Drug Administration (FDA) shared with Wedgewood Pharmacy in a phone call that the Agency will delay enforcing its Guidance for Industry #256, Compounding Animal Drugs from Bulk Drug Substances, which was slated to be begin on October 1, 2022, until April 2023.

Survey: Veterinary Practices Uninformed, Unprepared for FDA Guidance
in Press Room - 08/30/2022
A new nationwide poll of veterinary practices shows that 69% of veterinary practices are not confident they are prepared to comply with provisions of the Food & Drug Administration (FDA) Guidance for Industry #256, slated to be “enforced” beginning October 1, 2022. [Extended by FDA to April 2023.]

Wedgewood Pharmacy Joins Preferred Business Provider Network of American Animal Hospital Assn.
in Press Room - 08/02/2022
Wedgewood Pharmacy has been named the American Animal Hospital Association’s (AAHA) preferred provider for compounding services. AAHA has more than 4,500 accredited veterinary practice and hospital members.

NY Veterinarians Now Can Order Office-Use Compounds from FDA-Registered Outsourcing Facility
in Press Room - 07/26/2022
The New York State regulatory authorities have issued a license to Wedgewood Connect (San Jose CA) to offer compounded medications for office use to veterinarians in New York. Wedgewood Connect is the FDA-registered 503(B) Outsourcing Facility owned by Wedgewood Pharmacy.

Statement on FDA Guidance for Industry 256, Compounding Animal Drugs from Bulk Drug Substances
in Press Room - 04/13/2022
On April 13, the Food and Drug Administration (FDA)’s Center for Veterinary Medicine (CVM) published final Guidance for Industry 256 (GFI #256) Compounding Animal Drugs from Bulk Drug Substances. Wedgewood Pharmacy, the nation’s largest compounding pharmacy dedicated to animal health, issued the following statement in reaction to the final guidance.

Proposed Changes to USP Guidelines Would Have Negative Impact on Veterinarians and Patients
in Press Room - 02/05/2022
A new poll of veterinary practices shows that proposed changes to U.S. Pharmacopeia (USP) standards for setting the Beyond Use Dates (BUDs) of sterile compounded medications would have a negative impact on 95% of veterinary practices and 96% of their clients and patients. The poll was conducted in December 2021 by Wedgewood Pharmacy, the largest veterinary compounding pharmacy in the U.S.

Wedgewood Pharmacy Leads More Action to Advocate for Access To Compounded Medication
in Press Room - 12/02/2021
Wedgewood Pharmacy again took the lead in an industry-wide effort to make FDA’s Draft Guidance #256, Compounding Animal Drugs from Bulk Drug Substances, workable for veterinarians, pet owners, and compounding pharmacies that prepare medications for animal health.

Wedgewood Pharmacy Appoints Veterinary Advisory Board
in Press Room - 11/15/2021
Wedgewood Pharmacy, the largest compounding pharmacy in the U.S. devoted to animal-health, has created a Veterinary Advisory Board comprising 11 veterinarians. The goal of the Board is to support the company’s mission of improving the lives of animals and those who love them.

Wedgewood Pharmacy Executive Receives 2021 Compounding Advocacy Champion Award
in Press Room - 11/11/2021
Marcy A. Bliss, chief executive officer for Wedgewood Pharmacy, was named the 2021 recipient of the George and Lucy Malmberg Compounding Advocacy Champion Award by the Alliance for Pharmacy Compounding during a ceremony in Washington DC.

Compounders prevail: Judge rules in favor of compounders, against FDA in lawsuit over MOU
in Press Room - 09/22/2021
A federal district court judge has issued a summary judgment in favor of a group of compounding pharmacies, ruling that FDA’s MOU on interstate shipments of compounded drugs violated the law, and the agency cannot enforce it.

Vinay Bhatt Joins Wedgewood Pharmacy as as vice president, Quality and Compliance
in Press Room - 08/04/2021
Vinay Bhatt has joined Wedgewood Pharmacy as vice president, Quality and Compliance reporting to Joe Costa, president and chief operating officer.

Wedgewood Pharmacy Appoints Maria Kraus, CPA, as CFO
in Press Room - 06/24/2021
Wedgewood Pharmacy has appointed Maria Kraus, CPA to the newly created role of chief financial officer of the company.

Wedgewood Pharmacy Executive Receives 2021 Bowl of Hygeia Award for Arizona
in Press Room - 06/22/2021
Michael Blaire, R.Ph., FIACP, vice president Government and Regulatory Affairs for Wedgewood Pharmacy, has been named the 2021 recipient for Arizona of the Bowl of Hygeia Award, granted by a cooperative of national pharmacy associations.

Partners Group Completes Majority-Share Purchase of Wedgewood Pharmacy.
in Press Room - 04/05/2021
Leading global private-markets firm Partners Group has, on behalf of its clients, completed its purchase of the majority equity share of Wedgewood Pharmacy, the largest compounding pharmacy in the U.S. devoted to animal health. The signing of an agreement to purchase was announced previously on December 19, 2020. The firm replaces New Harbor Capital as the majority shareholder.

Partners Group Will Become New Majority Shareholder of Wedgewood Pharmacy.
in Press Room - 12/09/2020
Wedgewood Pharmacy has signed a definitive purchase agreement with Partners Group, on behalf of its clients, which will replace New Harbor Capital as its majority shareholder after the transaction closes in 2021. Terms of the transaction were not disclosed.

Wedgewood Connect Offers Ophthalmic Solutions for Office Use
in Press Room - 12/01/2020
Wedgewood Connect, the new FDA-registered, cGMP, 503B Outsourcing Facility subsidiary of Wedgewood Pharmacy, has begun to produce sterile medications for office use. The first products offered are five formulations of Cyclosporine Ophthalmic Solution and five formulations of Tacrolimus Ophthalmic Solution.

Wedgewood Pharmacy Submits GFI #256 Comments to FDA
in Press Room - 10/14/2020
Wedgewood Pharmacy submitted its formal comments to the Food & Drug Administration registering the company' strong and detailed opposition to key provisions of FDA's Draft Guidance for Industry #256: Compounding Animal Drugs from Bulk Drug Substances.

Wedgewood Pharmacy completes acquisition of Wildlife Pharmaceuticals and its subsidiary ZooPharm
in Press Room - 08/10/2020
Wedgewood Pharmacy has completed the acquisition of Wildlife Pharmaceuticals, Inc., Windsor, Colorado, and its wholly-owned pharmacy subsidiary, ZooPharm, Laramie, Wyoming. The companies serve veterinarians and patients in the wildlife and zoo markets. ZooPharm is a veterinary compounding pharmacy that provides veterinary-anesthesia and pain-management medications to care for non-domestic species, resident wildlife, captive exotic breeds, and companion animals.

Alliance for Pharmacy Compounding Reacts to Release of NASEM Studies
in Press Room - 07/02/2020
The Alliance for Pharmacy Compounding (APC) reacted to the release of two FDA-commissioned studies concerning compounded medications by the National Academies of Science, Engineering and Medicine (NASEM).

FDA extends comment period on GFI #256 to October 15, 2020.
in Press Room - 06/11/2020
The Food & Drug Administration announced today that it has extended the comment period for its draft guidance #256, “Compounding Animal Drugs from Bulk Drug Substances," by 120 days, to October 15, 2020.

AVMA and Congressional veterinarians ask FDA to extend #GFI 256 comment period again.
in Press Room - 05/23/2020
American Veterinary Medical Association and Congressional veterinarians ask FDA for additional extension of comment period on GFI #256 from 120 days to six months, citing Coronavirus pandemic's impact on ability to seek comment from constituents.

Wedgewood Pharmacy to Acquire 503B Outsourcing Facility and ZooPharm Specialty Pharmacy
in Press Room - 05/14/2020
Wedgewood Pharmacy reaches agreement to purchase equipment and facilities in a 22,000 square-foot, FDA-registered 503B outsourcing facility that is licensed in 45 U.S. states. The company also has agreed to acquire Wildlife Pharmaceuticals, Inc. and its subsidiary, ZooPharm.

Alliance for Pharmacy Compounding Asks FDA to Extend GFI #256 Comment Period Again.
in Press Room - 05/05/2020
APC requests additional 180-day extension to comment period for GFI #256.

Corona Virus (COVID-19) Our Commitment to Well-Being Update
in Press Room - 03/16/2020
With growing concern about COVID-19, Marcy Bliss, President and CEO shares additional steps we have taken to 1) ensure your access to prescriptions and 2) prevent the spread of illness.

USP Grants Compounding Pharmacies’ Appeal of Revisions to Compounding Rules
in Press Room - 03/12/2020
USP grants compounding pharmacies' appeal of proposed revisions to USP chapters <795> and <797> of the U.S. Pharmacopeia, which govern compounding of sterile and non-sterile preparations.

Pharmacy Coalition Pushes Back on FDA Draft GFI #256
in Press Room - 02/26/2020
Wedgewood Pharmacy and several other pharmacies that specialize in preparing compounded medication for animal patients submitted formal comments today to FDA about its proposed guidance, Compounding Animal Drugs from Bulk Drug Substances.

Veterinarians Report FDA’s Proposed Guidance Will Have Negative Impact
in Press Room - 01/08/2020
A new nationwide poll of veterinary practices confirms that new guidance proposed by the Food & Drug Administration (FDA) would have a significant negative impact on their practices and their patients’ health if issued and enforced.

FDA Issues New Draft Guidance That Threatens Veterinary Medicine
in Press Room - 12/18/2019
FDA’s Center for Veterinary Medicine (CVM) recently issued draft guidance (GFI #256) that, if finalized, threatens to have serious and damaging ramifications for your practice and your patients.

Legislative and regulatory victories for veterinarians gain momentum.
in Press Room - 05/28/2019
Adding to victories for veterinarians in Florida, Illinois, Georgia, and Mississippi, Minnesota has amended a relevant statute to clarify that veterinarians may order non-patient-specific compounded medications for office administration and dispensing.

Better Together: Joint effort leads to changes in Illinois rules.
in Press Room - 01/09/2019
The Illinois Department of Financial and Professional Responsibility (IDFPR), which regulates pharmacy practice in Illinois, issued proposed revisions to Illinois’ rules governing compounding pharmacies. Those rules would have restricted veterinarians' use of compounded medications. Wedgewood Pharmacy formed a coalition with several other compounding pharmacies—Diamondback Drugs, Pet Health Pharmacy, and Veterinary Pharmacies of America—to voice opposition to IDFPR’s proposed rules. Ultimately,

Ntl. survey of veterinarians shows negative impact of opioid shortages on veterinarians, pet owners,
in Press Room - 09/14/2018
A nationwide survey shows that there are unintended consequences for veterinary medicine caused by the Drug Enforcement Administration’s (DEA) efforts to address the national opioid crisis. According to the survey, these shortages have had the unintended results of creating unnecessary pain, suffering, and death of animals because alternatives are less effective and are more expensive.

Wedgewood Pharmacy and Diamondback Drugs Animal-Health Pharmacies Merge to Provide Greater Benefits
in Press Room - 07/17/2018
Two of the nation’s most-trusted animal-health compounding pharmacies, Wedgewood Pharmacy (Swedesboro, New Jersey) and Diamondback Drugs (Scottsdale, Arizona), have come together to increase the breadth of medications available, to improve the speed of delivery to veterinary practices and patients, and to evolve the service and quality available to the market today.

Wedgewood Pharmacy welcomes NJ Senator Dr. Jeff Van Drew
in Press Room - 07/12/2018
Wedgewood Pharmacy, one of the largest compounding pharmacies in the U.S., welcomed New Jersey State Senator Dr. Jeff Van Drew (D-1) to its pharmacy in Swedesboro yesterday. Van Drew toured the state-of-the art facilities, meeting with company executives and constituents to discuss the unique and critical role compounding plays in human and animal medicine, and the Congressional intent that it remain a state-licensed practice.

Wedgewood Pharmacy and Vetsource® partner to add commonly prescribed meds
in Press Room - 07/09/2018
Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, and Vetsource®, the only veterinary industry-endorsed Home-Delivery pharmacy provider, have partnered to add thousands of commonly prescribed compounded medications to Vetsource’s Home-Delivery catalog. Much of Wedgewood Pharmacy's formulary is now available to veterinarians and pet owners with prescription orders through the Vetsource platform.

Wedgewood Pharmacy Now Compounds Potassium Chloride During Shortage
in Press Room - 06/14/2018
Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, is now compounding preservative-free Potassium Chloride 40mEq/vial (2mEq/ml) Injection Solution, 20ml, during a shortage declared by the U.S. Food and Drug Administration (FDA). It is now available by prescription to licensed veterinarians and their patients directly through the pharmacy or at Order.WedgewoodPetRx.com.

There's a massive shortage of workers in N.J. These groups have a plan to fix it
in Press Room - 03/28/2018
There are employers across the state with 40,000 job openings and no qualified applicants to hire. In a program that's a first in New Jersey, there's a plan to provide employers with job-seekers.

Wedgewood Pharmacy & Vetsource partner to add commonly prescribed compounded meds to platform
in Press Room - 03/06/2018
Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, and Vetsource®, the only veterinary industry-endorsed Home-Delivery pharmacy provider, have partnered to add thousands of commonly prescribed compounded medications to Vetsource’s Home-Delivery catalog. Much of Wedgewood’s formulary will be available to veterinarians and pet owners with prescription orders through the Vetsource platform by late Spring 2018.

Wedgewood Pharmacy Now Compounds Omeprazole IM Injection Suspension
in Press Room - 02/01/2018
Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, is now compounding Omeprazole IM Injection Suspension, 100mg/ml in a 20ml vial. The preparation has been introduced in response to requests from veterinarians. It is available by prescription to licensed veterinarians and their patients directly through the pharmacy or at Order.WedgewoodPetRx.com.

Wedgewood Pharmacy welcomes U.S. Congressman Earl L. "Buddy" Carter (R-Georgia)
in Press Room - 10/31/2017
Wedgewood Pharmacy, the largest veterinary compounding pharmacy in the U.S., welcomed U.S. Congressman Earl L. "Buddy" Carter (R-GA) to its pharmacy in Swedesboro yesterday. Carter toured the state-of-the art facilities and met with company executives to discuss the unique and critical role compounding plays in veterinary medicine, and the Congressional intent that it remain a state-licensed practice.

Wedgewood Pharmacy receives annual Outstanding Employer Award from NJ Business & Industry Assn.
in Press Room - 10/19/2017
Wedgewood Pharmacy, the largest animal-health compounding pharmacy in the U.S., received the 2017 annual Award for Excellence from the New Jersey Business & Industry Association (NJBIA) at a ceremony yesterday at the Bridgewater (NJ) Marriott Hotel. The award was given in the Outstanding Employer Category to recognize the company’s creative and forward-looking approach to managing its workforce.

Wedgewood Pharmacy wins one of three P.E.T. Awards.
in Press Room - 08/02/2017
Wedgewood Pharmacy, the largest animal-health compounding pharmacy in the U.S., received the inaugural P.E.T. Award, given at the PSI Business Symposium on July 30 in Orlando, Fla. The award’s acronym stands for three vital components of veterinary practice success, People, Education and Training. Wedgewood Pharmacy was recognized as the Education winner for its substantial public affairs education work with veterinarians, state and federal legislators and regulators.

Lucy Malmberg, chairman of Wedgewood Pharmacy, receives veterinary- pharmacy industry award.
in Press Room - 03/03/2017
The American College of Veterinary Pharmacists (ACVP) presented the 2017 Earl W. “Bill” Bradley Award to Lucy Malmberg, R.Ph., F.A.C.A., F.A.C.V.P., chairman of the board of Wedgewood Pharmacy. Wedgewood Pharmacy is the largest U.S. compounding pharmacy specializing in animal health.

Wedgewood Pharmacy receives Marcum Innovator of the Year Award.
in Press Room - 10/27/2016
Wedgewood Pharmacy was awarded the fourth annual Marcum Innovator of the Year Award at a ceremony last evening at the Sugarhouse Casino in Philadelphia. The awards program recognizes the Greater Philadelphia metropolitan area’s most innovative individuals and organizations in their fields.

Wedgewood Pharmacy introduces Green Rabbit Rx E-prescribing tool
in Press Room - 09/27/2016
Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, has introduced Green Rabbit Rx, a new E-prescribing tool, with the new and improved features requested by veterinarians. It is available to licensed veterinarians at Order.WedgewoodPetRx.com.

New Harbor Capital completes majority equity investment in Wedgewood Pharmacy
in Press Room - 06/08/2016
New Harbor Capital, a Chicago-based private-equity firm, has completed a majority equity investment in privately held Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, addiction medicine and urology.

Wedgewood Pharmacy director of compliance, Anthony Grzib, R.Ph. elected to board of a national assoc
in Press Room - 03/28/2016
Anthony Grzib, R.Ph., director of Pharmacy Compliance for Wedgewood Pharmacy, has been elected to the 2016 board of directors of the International Academy of Compounding Pharmacists (IACP) by the IACP membership. The association represents more than 4,000 pharmacists, technicians and students who focus on the specialty practice of pharmacy compounding.

Wedgewood Pharmacy exhibits in Trenton
in Press Room - 03/14/2016
Wedgewood Pharmacy was one of 25 New Jersey companies that took to the halls of the New Jersey State House in Trenton today to showcase made-in-Jersey products and demonstrate their importance to the New jersey economy.

Wedgewood Pharmacy receives annual Award for Excellence from the New Jersey Business & Industry Asso
in Press Room - 10/15/2015
Wedgewood Pharmacy receives annual Award for Excellence from the New Jersey Business & Industry Association

Wedgewood Pharmacy welcomes New Jersey dignitaries
in Press Room - 08/17/2015
Wedgewood Pharmacy, one of the largest compounding pharmacies in the U.S., welcomed several New Jersey dignitaries to its compounding pharmacy and office facilities in Swedesboro last week.

Wedgewood Pharmacy welcomes Congressmen and NJBIA
in Press Room - 06/01/2015
Wedgewood Pharmacy, one of the largest compounding pharmacies in the U.S., welcomed several New Jersey dignitaries to its compounding laboratory and office facilities in Swedesboro during May: U.S. Congressman Frank Lobiondo (R-NJ), U.S. Congressman Donald Norcross (D-NJ), Michele Siekerka, Esq., president, and Frank Robinson, first vice president Grassroots and Government Affairs of the New Jersey Business and Industry Association.

Nominate Your Vet Tech for Superhero status (and a nice cash reward.)
in Press Room - 10/07/2014
October 12 - 18, 2014 is the 21st Annual National Veterinary Technician week. We're celebrating the occasion with a Facebook campaign to find and reward four vet techs who have extraordinary talents and super-human powers!

Wedgewood Pharmacy now compounds Doxycycline Quad tabs
in Press Room - 05/21/2014
Wedgewood Pharmacy is now compounding Doxycycline (as hyclate) with natural chicken flavor in its proprietary Quad tabs® dosage form. They are available in 100mg, 200mg and 300mg strengths.

Wedgewood Pharmacy is Accredited by the Better Business Bureau
in Press Room - 08/08/2013
Wedgewood Pharmacy has been Accredited by the Better Business Bureau (BBB) in New Jersey. BBB-Accredited Businesses are dedicated to ethical behavior and to building trust with customers

Lucy Malmberg receives annual award for compounding pharmacy advocacy leadership.
in Press Room - 06/05/2013
Lucy Malmberg, RPh, FACA, FACVP, senior executive vice president of Wedgewood Pharmacy (Swedesboro, NJ) and a resident of Sarasota FL and Wilmington DE, has received the annual Evelyn Timmons, RPh, Advocacy Award. The award is given annually by PCCA, a membership organization that strengthens the role, position and skills of member compounding pharmacists.

George J. Malmberg, chief executive officer of Wedgewood Pharmacy, passes away.
in Press Room - 04/22/2013
George J. Malmberg, RPh, FACA, FACVP, co-founder and chief executive officer of Wedgewood Pharmacy, passed away on April 22, 2013 in Wilmington, Delaware following a brief illness. He was 64.

Wedgewood Pharmacy launches Order.WedgewoodPetRx.com for veterinarians
in Press Room - 08/05/2011
Wedgewood Pharmacy launches Order.WedgewoodPetRx.com for veterinarians, a fast, easy and enjoyable way to search, compare and order compounded medications.

Lucy Malmberg elected to board of IACP
in Press Room - 01/11/2010
Lucy Malmberg, R.Ph., F.A.C.A., F.A.C.V.P., executive vice president and corporate secretary/treasurer of Wedgewood Pharmacy, has been elected to the board of directors of the International Academy of Compounding Pharmacists (IACP) for a three-year term that began January 1. She will represent the organization’s members in 12 states from Maine to Washington DC.


More News:
Partners Group Will Become New Majority Shareholder of Wedgewood Pharmacy
in Press Room - 12/09/2020
Wedgewood Pharmacy has signed a definitive purchase agreement with Partners Group, on behalf of its clients, which will replace New Harbor Capital as its majority shareholder after the transaction closes in 2021.

Lucy Malmberg elected to board of International Academy of Compounding Pharmacists
in Press Room - 01/11/2010
Lucy Malmberg, R.Ph., F.A.C.A., F.A.C.V.P., executive vice president and corporate secretary/treasurer of Wedgewood Pharmacy, has been elected to the board of directors of the International Academy of Compounding Pharmacists (IACP) for a three-year term that began January 1. She will represent the organization’s members in 12 states from Maine to Washington DC.

Wedgewood Pharmacy adds 90mg compounded thyroid tablets to formulary
in Press Room - 12/22/2009
In response to an increasing number of requests from physicians, Wedgewood Pharmacy announced that it will compound 90mg thyroid tablets during the long-term backorder of Forest Laboratories’ Armour® Thyroid tablets. Compounded using Thyroid USP powder, a naturally occurring thyroid, Wedgewood Pharmacy’s scored tablets are also dispensed in 15mg, 30mg, 60mg and 120mg.

Wedgewood Pharmacy introduces Tiny Tabs for Megestrol Acetate, Famciclovir
in Press Room - 11/30/2009
In response to requests from veterinarians, Wedgewood Pharmacy is now compounding Tiny Tabs™ in Megestrol Acetate 5mg and Famciclovir 31.25mg. Megestrol Acetate is commonly prescribed by veterinarians for behavioral- and dermatological-related conditions in felines, while Famciclovir is often prescribed for Feline Herpes (FHV-1) infections.

Wedgewood Pharmacy compounding cherry flavored oseltamivir phosphate suspension
in Press Room - 11/18/2009
Wedgewood Pharmacy is now compounding oseltamivir phosphate in a cherry-flavored suspension in response to the nationwide shortage of Tamiflu® suspension. The commercially manufactured Tamiflu product, from F. Hoffmann-La Roche Ltd, is offered in a 12mg/ml suspension (oseltamivir base) in a 25ml bottle. Wedgewood Pharmacy will fill prescriptions for oseltamivir 12mg/ml 25ml in a sugar-free cherry flavored suspension.

Wedgewood Pharmacy compounds Erythromycin During Manufacturer Backorder
in Press Room - 11/12/2009
While Erythromycin ophthalmic ointment is on extended backorder from the manufacturer, Wedgewood Pharmacy will compound this preparation for use in hospitals. Compounded Erythromycin ophthalmic ointment from Wedgewood Pharmacy meets US Pharmacopoeia guidelines <795> and <797> for compounding non-sterile and sterile preparations, and each tube is terminally sterilized before it is dispensed.

Wedgewood Pharmacy compounds thyroid tablets during manufacturer backorder of Armour Thyroid tablets
in Press Room - 11/05/2009
Wedgewood Pharmacy announced today that it is compounding thyroid tablets in response to physician demand during the long-term backorder of Forest Laboratories’ Armour Thyroid tablets. Compounded using Thyroid USP powder, a naturally occurring thyroid, Wedgewood Pharmacy’s scored tablets are available by prescription in 15mg, 30mg, 60mg and 120mg, with prices ranging from $21 to $25 per 100-count bottle. Thyroid tablets are commonly prescribed by physicians to treat hypothyroidism.

Wedgewood Pharmacy CEO receives highest Annual Alumni Award from Philadelphia School of Pharmacy
in Press Room - 09/28/2009
George J. Malmberg, R.Ph., F.A.C.A., F.A.C.V.P, the pharmacist president and chief executive officer of Wedgewood Pharmacy (Swedesboro NJ) was the 55th recipient of the Annual Alumni Award from the Philadelphia College of Pharmacy (PCP) of the University of the Sciences. It is the school’s highest alumni recognition, given for outstanding contributions to the profession, science and mankind. Malmberg, a resident of Wilmington DE, received the award at a ceremony Saturday evening.

Pergolide low-dust granules and non-chewable tablets now available from Wedgewood Pharmacy
in Press Room - 04/08/2009
Wedgewood Pharmacy has introduced custom-compounded Pergolide in two new dosage forms: flavored, low-dust granules and non-chewable tablets. The preparation commonly is prescribed to treat Cushing's syndrome in horses.

Wedgewood Pharmacy expands services offering in veterinary oncology
in Press Room - 01/15/2009
Wedgewood Pharmacy has expanded its oncology formulary to include both custom-compounded and manufactured chemotherapeutic and adjuvant agents. All medications are available by prescription for veterinary use only and are dispensed in dosage forms ranging from capsules and chewable treats to oral suspensions, ophthalmics and pre-filled syringes.


  • 1 (current)
  • 2